IMMX
Immix Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.22
+3.01%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-17.4%
Return on equity
-16.7%
Return on assets
-18.2%
Return on invested capital
0.00x
Asset turnover
-$38.5M
Cash from operations
$2.79
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026